Early Access

10-QPeriod: Q1 FY2002

EIDP, Inc. Quarterly Report for Q1 Ended Mar 31, 2002

Filed May 9, 2002For Securities:CTA-PBCTA-PA

Summary

E.I. du Pont de Nemours and Company (DuPont) reported consolidated sales of $6.14 billion for the first quarter of 2002, a decrease of 11% from $6.86 billion in the same period of 2001. This decline was primarily driven by lower sales volumes across most segments and a decrease in local selling prices, further impacted by a strong U.S. dollar. Net income for the quarter was $479 million, slightly down from $495 million in the prior year, resulting in diluted earnings per share of $0.48, compared to $0.47 in Q1 2001. The company adopted SFAS No. 142, eliminating goodwill amortization, which positively impacted reported earnings. However, the adoption of this standard also necessitates a goodwill impairment test by the end of 2002, with preliminary indications of potential impairment in two reporting units. Significant one-time items, including an exchange loss related to Argentina and charges from exiting joint ventures, also affected reported results. Management anticipates sequential volume improvements and year-over-year cost benefits in the second quarter, but expects these to be offset by currency headwinds and pricing pressures.

Key Highlights

  • 1Consolidated sales decreased 11% year-over-year to $6.14 billion, impacted by lower volumes and prices, and currency exchange rates.
  • 2Net income slightly decreased to $479 million, with diluted EPS at $0.48, compared to $495 million and $0.47 in Q1 2001.
  • 3Adoption of SFAS No. 142 eliminated goodwill amortization, but a goodwill impairment test is pending with potential charges identified.
  • 4The company experienced significant one-time items, including a $63 million exchange loss from Argentina and charges related to exiting joint ventures.
  • 5Cash flow from operations was negative $1.07 billion, heavily influenced by a large tax payment related to the DuPont Pharmaceuticals divestiture and seasonal working capital increases.
  • 6The company completed its previously authorized share repurchase program and continued to manage debt levels, with net debt increasing significantly.
  • 7Strategic actions are underway, including the planned separation of the Textiles & Interiors segment and a settlement of intellectual property disputes with Monsanto.

Frequently Asked Questions